Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
10.18
+0.03 (0.30%)
Jun 9, 2026, 3:49 PM EST
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 87,757 employees as of March 31, 2026. The number of employees decreased by 3,128 or -3.44% compared to the same quarter last year.
Employees
87,757
Change
-3,128
Growth
-3.44%
Revenue / Employee
$594,416
Profits / Employee
-$28,327
Market Cap
40.31B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 87,757 | -3,128 | -3.44% |
| Dec 31, 2025 | 87,280 | -4,584 | -4.99% |
| Sep 30, 2025 | 88,502 | -5,743 | -6.09% |
| Jun 30, 2025 | 89,556 | -7,011 | -7.26% |
| Mar 31, 2025 | 90,885 | -7,304 | -7.44% |
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Sep 30, 2024 | 94,245 | -6,628 | -6.57% |
| Jun 30, 2024 | 96,567 | -5,481 | -5.37% |
| Mar 31, 2024 | 98,189 | -3,546 | -3.49% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Sep 30, 2023 | 100,873 | -1,423 | -1.39% |
| Jun 30, 2023 | 102,048 | 134 | 0.13% |
| Mar 31, 2023 | 101,735 | 982 | 0.97% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Sep 30, 2022 | 102,296 | 2,482 | 2.49% |
| Jun 30, 2022 | 101,914 | 2,475 | 2.49% |
| Mar 31, 2022 | 100,753 | 1,424 | 1.43% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Veradigm | 2,300 |
| American Oncology Network | 1,914 |
| Glass House Brands | 426 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 68 |
| Vaxart | 65 |
| CytoDyn | 13 |
Bayer Aktiengesellschaft News
- 22 hours ago - Bayer appoints Reinhard as President of the Radiology business - TheFly
- 22 hours ago - Dr. Jost Reinhard Appointed President of Bayer's Radiology Business - Business Wire
- 1 day ago - Bayer announces leadership changes within Consumer Health division - TheFly
- 1 day ago - Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth - Business Wire
- 5 days ago - Bayer says Kerendia met primary endpoint in Phase III FIND-CKD trial - TheFly
- 5 days ago - Phase III FIND‑CKD Results Show Bayer's KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease - Business Wire
- 5 days ago - Phase III FIND‑CKD Results Show Bayer’s KERENDIA (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease - Wallstreet:Online
- 7 days ago - Bayer (BAYRY) Confirms No Plans to Spin Off Monsanto Amid Roundup Lawsuits - GuruFocus